Targeting cancer with engineered T cells
Dr. Philip Greenberg, head of immunology and a member of the Clinical Research Division at Seattle's Fred Hutchinson Cancer Research Center and a leader in cancer immunology, will describe how he and colleagues are genetically ...
Apr 20, 2016
0
4